Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1291583 single and multiple ascending dose study in healthy Japanese males
jRCT2071210111Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in bronchiectasis and chronic obstructive pulmonary disease (COPD) comparing BI 1291583 with Placebo (2 arms). Started Mar 2022; status: completed.
02
Drugs
verducatib
03
Conditions
bronchiectasischronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2071210111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210111.